Success Metrics

Clinical Success Rate
70.0%

Based on 7 completed trials

Completion Rate
70%(7/10)
Active Trials
0(0%)
Results Posted
71%(5 trials)
Terminated
3(23%)

Phase Distribution

Ph not_applicable
5
38%
Ph phase_4
4
31%
Ph phase_3
1
8%
Ph phase_2
2
15%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
4(33.3%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(7)
Terminated(3)
Other(3)

Detailed Status

Completed7
unknown3
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
70.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (16.7%)
Phase 31 (8.3%)
Phase 44 (33.3%)
N/A5 (41.7%)

Trials by Status

unknown323%
completed754%
terminated323%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DRUG
Total Trials
13